New drug TBD11 tested in humans for first time
NCT ID NCT06707142
First seen Jun 24, 2026 · Last updated Jun 24, 2026
Summary
This early-stage trial tested the safety and tolerability of a new drug called TBD11 in 124 healthy adults. Participants received either single or multiple doses of TBD11 or a placebo, and some took it with food to see if that changed how the drug behaves. The study is complete and focused on side effects and how the drug moves through the body, not on treating any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULT PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Celerion
Lincoln, Nebraska, 68502, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
TBD11
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.